Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aero...

FDA Drug Recall #D-0379-2015 — Class II — December 31, 2014

Recall Summary

Recall Number D-0379-2015
Classification Class II — Moderate risk
Date Initiated December 31, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Valeant Pharmaceuticals North America LLC
Location Bridgewater, NJ
Product Type Drugs
Quantity 2,428 vials

Product Description

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Reason for Recall

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Distribution Pattern

Nationwide and Australia

Lot / Code Information

Lot #: 340353F, Exp 10/2018

Other Recalls from Valeant Pharmaceuticals North America...

Recall # Classification Product Date
D-0487-2019 Class III Cardizem CD (diltiazem HCl) capsules, 120 mg, p... Jan 30, 2019
D-0490-2019 Class III Cardizem CD (diltiazem HCl) capsules, 300 mg, p... Jan 30, 2019
D-0488-2019 Class III Cardizem CD (diltiazem HCl) capsules, 180 mg, p... Jan 30, 2019
D-0491-2019 Class III Diltiazem HCl CD capsules, 360 mg, 90-count bot... Jan 30, 2019
D-0489-2019 Class III Cardizem CD (diltiazem HCl) capsules, 240 mg, p... Jan 30, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.